全文获取类型
收费全文 | 156073篇 |
免费 | 10729篇 |
国内免费 | 4164篇 |
专业分类
耳鼻咽喉 | 1766篇 |
儿科学 | 3455篇 |
妇产科学 | 4647篇 |
基础医学 | 22949篇 |
口腔科学 | 4278篇 |
临床医学 | 13923篇 |
内科学 | 27625篇 |
皮肤病学 | 2770篇 |
神经病学 | 10263篇 |
特种医学 | 5302篇 |
外国民族医学 | 26篇 |
外科学 | 20832篇 |
综合类 | 10907篇 |
现状与发展 | 12篇 |
一般理论 | 37篇 |
预防医学 | 10809篇 |
眼科学 | 3807篇 |
药学 | 14081篇 |
15篇 | |
中国医学 | 2696篇 |
肿瘤学 | 10766篇 |
出版年
2022年 | 1448篇 |
2021年 | 2641篇 |
2020年 | 1939篇 |
2019年 | 2238篇 |
2018年 | 2884篇 |
2017年 | 2341篇 |
2016年 | 2310篇 |
2015年 | 3174篇 |
2014年 | 3926篇 |
2013年 | 4224篇 |
2012年 | 6413篇 |
2011年 | 6801篇 |
2010年 | 4108篇 |
2009年 | 3495篇 |
2008年 | 5427篇 |
2007年 | 5685篇 |
2006年 | 5497篇 |
2005年 | 5151篇 |
2004年 | 4327篇 |
2003年 | 4073篇 |
2002年 | 3703篇 |
2001年 | 7550篇 |
2000年 | 7873篇 |
1999年 | 6701篇 |
1998年 | 2441篇 |
1997年 | 2037篇 |
1996年 | 1443篇 |
1995年 | 1347篇 |
1994年 | 1228篇 |
1993年 | 1066篇 |
1992年 | 4017篇 |
1991年 | 4097篇 |
1990年 | 3816篇 |
1989年 | 3774篇 |
1988年 | 3616篇 |
1987年 | 3449篇 |
1986年 | 3247篇 |
1985年 | 3091篇 |
1984年 | 2140篇 |
1983年 | 1860篇 |
1979年 | 1939篇 |
1978年 | 1209篇 |
1975年 | 1200篇 |
1974年 | 1365篇 |
1973年 | 1423篇 |
1972年 | 1361篇 |
1971年 | 1253篇 |
1970年 | 1141篇 |
1969年 | 1124篇 |
1968年 | 1026篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
目的探讨舒芬太尼在肾母细胞瘤患儿术后镇痛中的应用效果及对患儿免疫功能的影响。方法采用随机数字表法将42例肾母细胞瘤患儿分为低剂量、中剂量和高剂量组,每组14例,低剂量组、中剂量组、高剂量组患儿术后舒芬太尼镇痛剂量分别为1.0、2.5、4.0μg/kg。术后6、24、48 h,采用中文版儿童疼痛行为量表(FLACC)评估三组患儿的镇痛效果,以及不良反应发生情况;麻醉前和术后1、24、72 h,检测三组患儿免疫功能指标,包括免疫球蛋白(Ig)G、IgA、IgM。结果术后6、24、48 h,中剂量组、高剂量组患儿FLACC评分均低于低剂量组患儿,差异均有统计学意义(P﹤0.05)。术后1、24、72 h,低剂量组患儿IgG、IgA、IgM水平均低于本组麻醉前,差异均有统计学意义(P﹤0.05);术后1、24 h,中剂量组和高剂量组患儿IgG、IgA、IgM水平均低于本组麻醉前,差异均有统计学意义(P﹤0.05),但术后72 h,中剂量组和高剂量组患儿IgG、IgA、IgM水平与麻醉前比较,差异均无统计学意义(P﹥0.05)。低剂量组患儿未发生不良反应,中剂量组患儿发生恶心1例,高剂量组患儿发生恶心5例、呕吐3例。结论2.5μg/kg的舒芬太尼在肾母细胞瘤患儿术后镇痛中效果明显,且对患儿的免疫系统发挥一定的保护作用,可以减轻患儿术后免疫功能抑制。 相似文献
13.
C.Z. Simonsen S. Schnenberger P.L. Hendn A.J. Yoo L. Uhlmann A. Rentzos J. Bsel J. Valentin M. Rasmussen 《AJNR. American journal of neuroradiology》2020,41(12):2298
BACKGROUND AND PURPOSE:Endovascular therapy for acute ischemic stroke is often performed with the patient under conscious sedation. Emergent conversion from conscious sedation to general anesthesia is sometimes necessary. The aim of this study was to assess the functional outcome in converted patients compared with patients who remained in conscious sedation and to identify predictors associated with the risk of conversion.MATERIALS AND METHODS:Data from 368 patients, included in 3 trials randomizing between conscious sedation and general anesthesia before endovascular therapy (SIESTA, ANSTROKE, and GOLIATH) constituted the study cohort. Twenty-one (11%) of 185 patients randomized to conscious sedation were emergently converted to general anesthesia.RESULTS:Absence of hyperlipidemia seemed to be the strongest predictor of conversion to general anesthesia, albeit a weak predictor (area under curve = 0.62). Sex, hypertension, diabetes, smoking status, atrial fibrillation, blood pressure, size of the infarct, and level and side of the occlusion were not significantly associated with conversion to general anesthesia. Neither age (mean age, 71.3 ± 13.8 years for conscious sedation versus 71.6 ± 12.3 years for converters, P = .58) nor severity of stroke (mean NIHSS score, 17 ± 4 versus 18 ± 4, respectively, P = .27) were significantly different between converters and those who tolerated conscious sedation. The converters had significantly worse outcome with a common odds ratio of 2.67 (P = .015) for a shift toward a higher mRS score compared with the patients remaining in the conscious sedation group.CONCLUSIONS:Patients undergoing conversion had significantly worse outcome compared with patients remaining in conscious sedation. No factor was identified that predicted conversion from conscious sedation to general anesthesia.Five studies published in 2015 proved the efficacy of endovascular therapy (EVT) for acute ischemic stroke caused by a large-vessel occlusion.1 However, numerous questions remain regarding how to best deliver this treatment, including evaluation of the optimal thrombectomy technique,2 the most effective method of patient triage,3 or whether EVT should be performed with the patient under either general anesthesia (GA) or conscious sedation (CS).Observational studies have suggested that EVT with the patient under CS is associated with better neurologic outcome and lower mortality compared with GA.4 However, 3 randomized trials reported similar outcomes between CS and GA.5-7 Proposed benefits of CS include stable hemodynamics, clinical monitoring, and a potentially shorter procedure. The disadvantages are an unprotected airway and patient movement, which sometimes may require emergent conversion to GA. Patients who need conversion might be sicker (larger strokes, more medical complications), but the conversion procedure itself may also have a potentially deleterious influence on outcome due to the emergent anesthetic induction, associated hypotension, and added time delay before reperfusion.Although most patients can be treated under the less complex CS, it is of interest to identify factors that can predict the risk of conversion and hence the requirement for GA. We undertook a detailed analysis of the patients who were converted from CS to GA in our individual patient data base from the 3 randomized trials to examine the outcome of the converted patients compared with patients who remained in CS. We also aimed to identify possible predictors associated with a need for GA with EVT. 相似文献
14.
Xin Yi Wong Andrew Qi Jun Lim Qianyu Shen John Whay Kuang Chia Min Hoe Chew Wah Siew Tan 《Current medical research and opinion》2020,36(10):1677-1686
Abstract
Objective
Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies. 相似文献15.
16.
17.
18.
沈曙铭 《中华口腔医学杂志》2020,(4):241-245
突发公共卫生事件应急管理是一个全球性的课题。本文就2019年12月以来发生在中国的新型冠状病毒肺炎这一突发公共卫生事件,口腔医疗机构及其从业人员面临的相关问题进行法律层面的分析与思考,以期对口腔医疗行业应对突发公共卫生事件提供帮助和指导。 相似文献
19.
Assessment of Myocardial Infarct Size by Three‐Dimensional and Two‐Dimensional Speckle Tracking Echocardiography: A Comparative Study to Single Photon Emission Computed Tomography
下载免费PDF全文
![点击此处可从《Echocardiography (Mount Kisco, N.Y.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
20.